Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus salivarius UCC118 and Reduced Risk of Infection

Research synthesisLow evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial moderate-sized effects of Lactobacillus salivarius UCC118 on reducing risk of infection. However, all studies are review articles without original trial data, and no specific dose range, population, or form was consistently studied.

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive, but clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). No individual studies reported statistical significance, and all are reviews rather than original controlled trials — the true effect may be smaller or less certain than the predominant direction suggests.

Generated Jul 12, 2026
3 of 3 papers
Back to top